measuregroup/AID297855

Predicate	Object
has specified output	http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103527550_AID297855_PMID17705362_VALUE6 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103527548_AID297855_PMID17705362_VALUE5 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103527544_AID297855_PMID17705362_VALUE3 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103527547_AID297855_PMID17705362_VALUE4 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103527543_AID297855_PMID17705362_VALUE2 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID123086577_AID297855_PMID17705362_VALUE7 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103527543_AID297855_PMID17705362_VALUE1
has participant	http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP04150
source	http://rdf.ncbi.nlm.nih.gov/pubchem/source/ChEMBL
title	Antagonist efficacy at human GR expressed in CV1 cells by GRE activation assay relative to Dexamethasone
type	http://www.bioassayontology.org/bao#BAO_0000040

Predicate	Subject
participates in	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103527547 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103527548 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID123086577 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103527543 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103527550 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103527544
has measure group	http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID297855

Total number of triples: 18.